According to Biofrontera's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.162811. At the end of 2023 the company had a P/S ratio of 0.1234.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.1234 | -85.54% |
2022 | 0.8535 | -81.83% |
2021 | 4.70 |